← FDA DRUG APPROVALS

FDA ANDA · ANDA072687

FOAMICON

Sponsor: NOVARTIS

APPLICATION
ANDA072687
TYPE
ANDA
ORIGINAL APPROVAL
1989-06-28
LATEST ACTION
1996-05-24
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

FOAMICONDiscontinued
ALUMINUM HYDROXIDE 80MG, MAGNESIUM TRISILICATE 20MG · TABLET, CHEWABLE · ORAL

Approval history

1996-05-24Labeling · Supplement 3AP
1996-05-24Manufacturing (CMC) · Supplement 1AP
1996-05-24Manufacturing (CMC) · Supplement 2AP
1989-06-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →